Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minidose LSD for chronic cluster headache
NL-OMON60980Phase 2Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cluster Headache (CH) comparing LSD with Placebo (2 arms). Started Apr 2025; status: recruiting.
02
Drugs
Lysergide
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NL-OMON60980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60980.